Triple

T5377430
Position Surface form Disambiguated ID Type / Status
Subject Lincoln College, Oxford E112995 entity
Predicate hasAlumni P51 FINISHED
Object Howard Florey E339765 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Howard Florey | Statement: [Lincoln College, Oxford, hasAlumni, Howard Florey]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Howard Florey
Context triple: [Lincoln College, Oxford, hasAlumni, Howard Florey]
  • A. Howard Florey chosen
    Howard Florey was an Australian pharmacologist and pathologist who shared the Nobel Prize in Physiology or Medicine for his pivotal role in developing penicillin into a practical antibiotic treatment.
  • B. Sir Frederick Gowland Hopkins
    Sir Frederick Gowland Hopkins was an English biochemist and Nobel laureate renowned for discovering essential nutrients later known as vitamins and for pioneering the field of nutritional biochemistry.
  • C. Harold Hodgkin
    Harold Hodgkin is a notable individual who shares the Hodgkin surname, which is associated with several prominent figures in science and medicine.
  • D. Sir James Black
    Sir James Black was a Scottish pharmacologist and Nobel laureate renowned for developing the first beta-blocker and the H2 receptor antagonist cimetidine, revolutionizing treatments for heart disease and peptic ulcers.
  • E. Julius Ehrlich
    Julius Ehrlich is a notable individual associated with the surname Ehrlich, recognized as a distinguished bearer of that name.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69bd4436a1988190af18dcff7fd306b4 completed March 20, 2026, 12:57 p.m.
NER Named-entity recognition batch_69bd86cb13ac81909dc364e7d3605844 completed March 20, 2026, 5:41 p.m.
NED1 Entity disambiguation (via context triple) batch_69bf29428cec8190a20bea8fcae59d8f completed March 21, 2026, 11:26 p.m.
Created at: March 20, 2026, 2:03 p.m.